Clinical Trial Update: Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ferric derisomaltose to support recovery after gynecologic cancer surgery within an Enhanced Recovery After Surgery (ERAS) p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer
• Iron Deficiency Anemia

Drugs mentioned

• Ferric derisomaltose (ferric derisomaltose)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Gynecologic Cancer, Anemia | Phase 3 | Status: RECRUITING